Data / Form D filings / SCOLR Pharma, Inc.
SCOLR Pharma, Inc.: Form D filings
SCOLR Pharma, Inc., a pharmaceuticals company in Bellevue, WA, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on May 18, 2012, reports $308,000 sold of a $1.4 million offering to 7 investors.
Find out what SCOLR Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13400 NE 20TH STREET, SUITE 44, Bellevue, WA, 98005
- Phone
- (425) 368-1050
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 934936
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2012 | New notice | $1,350,000 | $308,000 | $1,042,000 | 7 | May 4, 2012 | sec.gov |
| Jun 30, 2011 | Amendment | $1,195,200 | $1,195,200 | $0 | 82 | Jun 16, 2011 | sec.gov |
| Jun 23, 2011 | New notice | $1,750,000 | $1,001,200 | $748,800 | 62 | Jun 16, 2011 | sec.gov |
| Mar 18, 2010 | New notice | $4,130,000 | $4,130,000 | $0 | 123 | Mar 4, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MaryLou W. Arnett | Director | |
| Michael N. Taglich | Director | |
| Wayne L Pines | Director | |
| Herbert L. Lucas | Director | |
| Jeffrey B. Reich | Director | |
| Stephen J. Turner | Executive Officer | |
| Carl J. Johnson | Director |
Other pharmaceuticals companies in Washington that filed recently
- Aptevo Therapeutics Inc. $3.5 million · Aug 26, 2026
Every Form D from the week of May 14, 2012 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SCOLR Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.